Psychometric properties of the Measurement of Current Status (MOCS) Scale in Mexican cancer patients
Propiedades psicométricas de la Escala de Medida del Estado Actual (MOCS) en pacientes mexicanos con cáncer
Propriedades psicométricas da Escala de Medida do Estado Atual (MOCS) em pacientes mexicanos com câncer
2023 | |
stress cancer México validation study MOCS estrés cáncer México Estudio de validación pruebas psicológicas estresse câncer testes psicológicos México estudo de validação |
|
Inglés | |
Universidad Católica del Uruguay | |
LIBERI | |
https://revistas.ucu.edu.uy/index.php/cienciaspsicologicas/article/view/3009 | |
Acceso abierto |
Sumario: | Background: Cancer is a public health problem, and stress is one of the psychosocial variables associated to this disease, which calls for the need to have a reliable scale to measures stress in the Hispanic population with cancer. Objective: To determine the psychometric properties of the Measurement of Current Status (MOCS) Scale in Mexican cancer patients. Method: Study design: Cross-sectional, non-experimental instrumental. A total of 197 patients aged 18-81 years, at any clinical stage, receiving cancer treatment or follow-up were included. Instruments: MOCS and emotional distress thermometer. Statistical analysis: Confirmatory factor analysis was performed to evaluate the fit of the model to the data using the maximum likelihood estimation and cut-off points. Results: Two models were obtained. The first, self-perceived current state, had an alpha of .90 with an explained variance of 74.2 %; the second, non-specific effect, with an alpha of .61 and an explained variance of 74.3 %. The confirmatory factor analysis showed that both models had indexes suggesting stability and acceptable adjustment. Scores are shown by interquartile ranges for each model. Conclusions: The Mexican version of the MOCS is reliable and valid; with a confirmatory factor structure similar to the original version. Therefore, we support its use in the clinical and research setting with cancer patients. |
---|